Treating ALK-positive non-small cell lung cancer

Targeting genomic alterations, such as epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) gene rearrangements, have radically changed the treatment of patients with non-small cell lung cancer (NSCLC). In the case of ALK-rearranged gene, subsequent rapid developmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Ziogas, Dimitrios C., Tsiara, Anna, Tsironis, Georgios, Lykka, Maria, Liontos, Michalis, Bamias, Aristotelis, Dimopoulos, Meletios-Athanasios
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2018
Assuntos:
Review Article on Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5952030/
https://ncbi.nlm.nih.gov/pubmed/29862230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.11.34
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados